{"nctId":"NCT00415623","briefTitle":"A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient","startDateStruct":{"date":"2007-01"},"conditions":["Hypertension"],"count":305,"armGroups":[{"label":"Amlodipine 5mg","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Amlodipine"]},{"label":"Amlodipine 10mg","type":"EXPERIMENTAL","interventionNames":["Drug: Amlodipine"]}],"interventions":[{"name":"Amlodipine","otherNames":[]},{"name":"Amlodipine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Untreated Hypertensive Patients: An systolic blood pressure of \\>=160 mmHg or diastolic blood pressure \\>=100mmHg.\n* Treated Hypertensive Patients: An systolic blood pressure of \\>=140 mmHg or diastolic blood pressure of \\>= 90 mmHg.\n* Patients with insufficient response to 5 mg of amlodipine in the screening period:Two successive systolic blood pressure measurements at Visit 4 (Week -2) and Visit 5 (Week 0 = baseline) \\>=140 mmHg\n* Patients with a screening treatment compliance rate \\>= 80%\n\nExclusion Criteria:\n\n* Subjects with secondary hypertension (renal disease, pheochromocytoma, and Cushing's syndrome, etc.), severe hypertension (systolic blood pressure of 180 mmHg or higher, or diastolic blood pressure of 110 mmHg or higher), and malignant hypertension","healthyVolunteers":false,"sex":"ALL","minimumAge":"20 Years","maximumAge":"79 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Systolic Blood Pressure (SBP) From Baseline to Week 8","description":"Mean change in the trough SBP","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-7.0","spread":null},{"groupId":"OG001","value":"-13.7","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Diastolic Blood Pressure (DBP) From Baseline to Week 8","description":"Mean change in the trough DBP","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.7","spread":null},{"groupId":"OG001","value":"-6.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Combined Mean Change in SBP From Baseline to Week 6 and Week 8 (Mean by Patient)","description":"Arithmetic mean of Week 6 \\& Week 8 by patient for \"Change from baseline in SBP at Week 6\" and \"Change from baseline in SBP at Week 8\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-6.8","spread":null},{"groupId":"OG001","value":"-13.9","spread":null}]}]}]},{"type":"SECONDARY","title":"Combined Mean Change in DBP From Baseline to Week 6 and Week 8 (Mean by Patient)","description":"Arithmetic mean of Week 6 \\& Week 8 by patient for \"Change from baseline in DBP at Week 6\" and \"Change from baseline in DBP at Week 8\"","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-2.5","spread":null},{"groupId":"OG001","value":"-6.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Achieving the Target Blood Pressure Reduction Value at Week 8","description":"Target blood pressure reduction value based on Japan Society of Hypertension Guidelines for the Management of Hypertension 2004: SBP below 130 mmHg and DBP below 85 mmHg for \\<=64 years old; SBP below 140 mmHg and DBP below 90 mmHg for \\>=65 years old","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"43","spread":null},{"groupId":"OG001","value":"66","spread":null}]}]}]},{"type":"SECONDARY","title":"Combined Number of Subjects Achieving the Target Blood Pressure Reduction Value at Both Weeks 6 and 8","description":"Target blood pressure reduction value based on Japan Society of Hypertension Guidelines for the Management of Hypertension 2004: SBP below 130 mmHg and DBP below 85 mmHg for \\<=64 years old; SBP below 140 mmHg and DBP below 90 mmHg for \\>=65 years old","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22","spread":null},{"groupId":"OG001","value":"52","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Achieving the Target Blood Pressure Reduction Value and Whose SBP Decreased From Baseline by >= 10 mmHg at Week 8","description":"Target blood pressure reduction value based on Japan Society of Hypertension Guidelines for the Management of Hypertension 2004: SBP below 130 mmHg and DBP below 85 mmHg for \\<=64 years old; SBP below 140 mmHg and DBP below 90 mmHg for \\>=65 years old","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35","spread":null},{"groupId":"OG001","value":"61","spread":null}]}]}]},{"type":"SECONDARY","title":"Combined Number of Subjects Achieving the Target Blood Pressure Reduction Value and Whose SBP Decreased From Baseline by >= 10 mmHg at Both Weeks 6 and 8","description":"Target blood pressure reduction value based on Japan Society of Hypertension Guidelines for the Management of Hypertension 2004: SBP below 130 mmHg and DBP below 85 mmHg for \\<=64 years old; SBP below 140 mmHg and DBP below 90 mmHg for \\>=65 years old","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"16","spread":null},{"groupId":"OG001","value":"44","spread":null}]}]}]},{"type":"SECONDARY","title":"Trough Plasma Concentrations of Amlodipine -Amlodipine 5 mg","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.02","spread":null},{"groupId":"OG001","value":"6.83","spread":null},{"groupId":"OG002","value":"7.03","spread":null}]}]}]},{"type":"SECONDARY","title":"Trough Plasma Concentrations of Amlodipine -Amlodipine 10 mg","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.18","spread":null},{"groupId":"OG001","value":"16.9","spread":null},{"groupId":"OG002","value":"16.9","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":null,"commonTop":[]}}}